Newron Pharmaceuticals S.p.A., a biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson’s in the European... Newron Pharmaceuticals S.p.A., a biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson’s in the European Union, the United Kingdom, the United States, Latin America, Switzerland, and Japan. The company’s lead compound includes Evenamide, an add-on therapy for the treatment of Schizophrenia and treatment-resistant schizophrenia, which is in Phase III clinical trial; and Ralfinamide for the treatment of rare neuropathic pain indication. It has a strategic partnership with Zambon and Meiji Seika Pharma Co., Ltd. for the commercialization of safinamide. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -2.2 | -14.2394822006 | 15.45 | 15.45 | 12.8 | 8952 | 13.55596837 | DE |
| 4 | -1.65 | -11.0738255034 | 14.9 | 16.75 | 12.8 | 5238 | 14.71606367 | DE |
| 12 | -5.01 | -27.4370208105 | 18.26 | 19 | 12.75 | 5320 | 15.80418805 | DE |
| 26 | -7.05 | -34.7290640394 | 20.3 | 34.15 | 12.75 | 7012 | 21.35649936 | DE |
| 52 | 4.75 | 55.8823529412 | 8.5 | 34.15 | 7.05 | 6068 | 17.470006 | DE |
| 156 | 8.89 | 203.899082569 | 4.36 | 34.15 | 4.2 | 7353 | 10.86854761 | DE |
| 260 | 10.87 | 456.722689076 | 2.38 | 34.15 | 1.13 | 5644 | 9.66751037 | DE |
SDCRBS
4分前
stockanalyze
5分前
NebraskaOTC
5分前
Diogenes of Sinope
6分前
Krombacher
8分前
LTR
13分前
Nemesis18
15分前
SSKILLZ1
15分前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。